Reproterol
Chemical compound / From Wikipedia, the free encyclopedia
Reproterol is a short-acting[1] β2 adrenoreceptor agonist used in the treatment of asthma.[2]
Quick Facts Clinical data, AHFS/Drugs.com ...
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Inhalation (MDI), IV |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.579 |
Chemical and physical data | |
Formula | C18H23N5O5 |
Molar mass | 389.412 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close
It was patented in 1965 and came into medical use in 1977.[3]